GlobeNewswire by notified

Major institutional equity mandate to be benchmarked to Scientific Beta climate index

Share

Press Release – January 17, 2023

Major institutional equity mandate to be benchmarked to Scientific Beta climate index

French additional civil service pension scheme benchmarks circa €300m mandate to Scientific Beta climate impact consistent index

One of the most prominent pension schemes in Europe, the €41.7bn additional pension scheme for French civil servants, ERAFP, had announced that it was awarding a circa €300m mandate to be benchmarked to the Scientific Beta Eurozone Climate Impact Consistent EU PAB Compliant index, and the corresponding fund has now been launched. The choice of index reflects ERAFP's climate commitments, made notably within the framework of the Net Zero Asset Owner Alliance (NZAOA).

The decision by ERAFP is a major vote of confidence in Scientific Beta's Climate Impact Consistent index offering. Since 2021, Scientific Beta has been offering these indices with pure climate objectives that allow climate exclusions and weightings to be combined in order to translate companies' climate alignment engagement into portfolio decisions.

The mandate will be awarded for a four-year term, twice renewable for one year, bringing the maximum term of the mandate to six years, and must be managed while respecting the socially responsible investing principles under which all of ERAFP's allocations have been managed since 2005.

Commenting on this announcement, Kin Yee Ng, CEO of Scientific Beta, said, "We are gratified that ERAFP has seen fit to award such a significant mandate on the basis of Scientific Beta's climate impact consistent (CIC) indices. The CIC index is the result of robust research that delivers a consistent climate offering on the market. Traditional climate indices and benchmarks, which combine financial and climate criteria, frequently lead to contradictions with compromised climate impact. We believe our CIC indices' strict focus on climate objectives raises the bar for climate action."


About Scientific Beta:
Scientific Beta aims to be the first provider of a smart factor and ESG/climate index platform to help investors understand and invest in advanced factor and ESG/climate equity strategies. Established by EDHEC-Risk Institute, one of the top academic institutions in the field of fundamental and applied research for the investment industry, Scientific Beta shares the same concern for scientific rigour and veracity, which it applies to all the services that it offers investors and asset managers.

On January 31, 2020, Singapore Exchange (SGX) acquired a majority stake in Scientific Beta. SGX is maintaining the strong collaboration with EDHEC Business School, and principles of independent, empirical-based academic research, that have benefited Scientific Beta's development to date. Since 2015, Scientific Beta has also been offering highly advanced strategies in the area of ESG and climate change, whether involving options integrated into smart beta indices or pure ESG or climate benchmarks.

As a complement to its own research, Scientific Beta supports an important research initiative developed by EDHEC on ESG and climate investing and cooperates with V.E and ISS ESG for the construction of its ESG and climate indices.

Scientific Beta, 2 Shenton Way, #02-02, SGX Centre I, Singapore 068804. For further information, please contact:
contact@scientificbeta.com, Web: www.scientificbeta.com

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update8.5.2024 22:15:38 CEST | Press release

Petosemtamab in combination with pembrolizumab in 1L HNSCC initial interim clinical data at 2024 ASCO Annual Meeting; preparing for a potential phase 3 trial Zeno BLA accepted for priority review by the FDA for the treatment of NRG1+ NSCLC and PDACBased on the Company’s current operating plan, existing cash, cash equivalents and marketable securities expected to fund Merus’ operations into 2027 UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced financial results for the first quarter and provided a business update. “At the upcoming 2024 ASCO meeting, we are looking forward to presenting multiple datasets including the first clinical data on safety and efficacy of petosemtamab in combination with pembrolizumab in previously untreated head and neck cancer. With p

CrossAmerica Partners LP Reports First Quarter 2024 Results8.5.2024 22:15:00 CEST | Press release

Allentown, PA, May 08, 2024 (GLOBE NEWSWIRE) -- CrossAmerica Partners LP Reports First Quarter 2024 Results Reported First Quarter 2024 Net Loss of $17.5 million that includes a $15.9 million loss on lease terminations with Applegreen, Adjusted EBITDA of $23.6 million and Distributable Cash Flow of $11.7 million compared to a Net Loss of $1.0 million, Adjusted EBITDA of $31.7 million and Distributable Cash Flow of $19.1 million for the First Quarter 2023Reported First Quarter 2024 Gross Profit for the Wholesale Segment of $27.0 million compared to $31.2 million of Gross Profit for the First Quarter 2023 and First Quarter 2024 Gross Profit for the Retail Segment of $54.4 million compared to $50.8 million of Gross Profit for the First Quarter 2023Leverage, as defined in the CAPL Credit Facility, was 4.49 times as of March 31, 2024, compared to 4.21 times as of December 31, 2023The Distribution Coverage Ratio for the trailing twelve months ended March 31, 2024 was 1.37 times compared to 1

Oculis Reports Q1 2024 Financial Results and Provides Company Updates8.5.2024 22:10:00 CEST | Press release

ZUG, Switzerland, May 08, 2024 (GLOBE NEWSWIRE) -- Clinical programs progressing as planned with initiation of second OCS-01 Phase 3 DIAMOND-2 trial in Diabetic Macular Edema (DME) and completion of enrollment in OCS-02 (licaminlimab) Phase 2b RELIEF trial in Dry Eye Disease (DED); RELIEF topline results anticipated in Q2 2024Completed $59 million registered direct equity offering and concurrent listing on Nasdaq Iceland Main Market in April 2024, extending cash runway into the second half of 2026Strengthened executive leadership team and U.S. presence with the appointments of accomplished and seasoned professionals as President of Research & Development and Chief Human Resources Officer Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced results for the three-month period ended March 31, 2024, and an overview of the Company’s progress. Riad Sherif M.D., Chief

Nokia Corporation: Repurchase of own shares on 08.05.20248.5.2024 21:30:00 CEST | Press release

Nokia Corporation Stock Exchange Release 08 May 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 08.05.2024 Espoo, Finland – On 08 May 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL362,9483.49CEUX--BATE--AQEU--TQEX--Total362,9483.49 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of tra

Trading in GN Store Nord shares by board members, executives and associated persons8.5.2024 21:28:31 CEST | Press release

GN Store Nord has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in GN Store Nord made by persons discharging managerial responsibilities in GN Store Nord and/or persons closely associated with them. Details of the person discharging managerial responsibilities/person closely associated Name Jørgen Bundgaard Hansen Reason for the notification Position/status Member of the Board of Directors Initial notification/Amendment Initial notification Details of the issuer Name GN Store Nord A/S LEI 5493008U3H3W0NKPFL10 Details of the transaction(s) Description of the financial instrument, type of instrument Identification code Shares DK0010272632 Nature of the transaction Purchase of shares Price(s) and volume(s) Price(s) DKK 201.0 DKK 201.1 DKK 201.1 DKK 201.0 DKK 201.0 DKK 201.0 DKK 201.1 DKK 201.1 DKK 201.2 DKK 201.2 DKK 201.2 DKK 201.0 DKK 201.3 DKK 201.2 DKK 201.2 DKK 201.2 DKK 201.2 DKK 201.2 DKK 201.3 DKK 201.5 DKK

HiddenA line styled icon from Orion Icon Library.Eye